AMERICAN SHARED HOSPITAL SERVICES Proceeds from Issuance of Subordinated Long-term Debt
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Proceeds from Issuance of Subordinated Long-term Debt of $570.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSubordinatedLongTermDebt · last filed 2017-03-27
- AMERICAN SHARED HOSPITAL SERVICES proceeds from issuance of subordinated long-term debt for the quarter ending 2016-12-31 was $570.00K.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from issuance of subordinated long-term debt for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from issuance of subordinated long-term debt for the quarter ending 2016-06-30 was -$1.14M, a 211.14% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from issuance of subordinated long-term debt for the quarter ending 2016-03-31 was $1.14M.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from issuance of subordinated long-term debt for fiscal 2016 was $570.00K, a 43.90% decline from fiscal 2015.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from issuance of subordinated long-term debt for fiscal 2015 was $1.02M, a 61.30% decline from fiscal 2014.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from issuance of subordinated long-term debt for fiscal 2014 was $2.63M, a 102.23% increase from fiscal 2013.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from issuance of subordinated long-term debt for fiscal 2013 was $1.30M, a 85.92% decline from fiscal 2012.
| Period end | Proceeds from Issuance of Subordinated Long-term Debt 3 month | Proceeds from Issuance of Subordinated Long-term Debt 6 month | Proceeds from Issuance of Subordinated Long-term Debt 9 month | Proceeds from Issuance of Subordinated Long-term Debt 12 month |
|---|---|---|---|---|
| 2016-12-31 | $570.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $570.00K derived: sum of 2 quarters · filed 2017-03-27 | -$567.00K derived: sum of 3 quarters · filed 2017-03-27 | $570.00K 10-K · filed 2017-03-27 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$1.14M derived: sum of 2 quarters · filed 2016-11-10 | $0.00 10-Q · filed 2016-11-10 | -$20.00K derived: sum of 4 quarters · filed 2017-03-27 |
| 2016-06-30 | -$1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $0.00 10-Q · filed 2016-08-11 | -$20.00K derived: sum of 3 quarters · filed 2017-03-27 | -$7.00K derived: sum of 4 quarters · filed 2017-03-27 |
| 2016-03-31 | $1.14M 10-Q · filed 2016-05-12 | $1.12M derived: sum of 2 quarters · filed 2017-03-27 | $1.13M derived: sum of 3 quarters · filed 2017-03-27 | $2.15M derived: sum of 4 quarters · filed 2017-03-27 |
| 2015-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | -$7.00K derived: sum of 2 quarters · filed 2017-03-27 | $1.02M derived: sum of 3 quarters · filed 2017-03-27 | $1.02M 10-K · filed 2017-03-27 |
| 2015-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.04M derived: sum of 2 quarters · filed 2016-11-10 | $1.04M 10-Q · filed 2016-11-10 | $3.66M derived: sum of 4 quarters · filed 2017-03-27 |
| 2015-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $1.02M 10-Q · filed 2016-08-11 | $3.65M derived: sum of 3 quarters · filed 2017-03-27 | $3.65M derived: sum of 4 quarters · filed 2017-03-27 |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-12 | $2.63M derived: sum of 2 quarters · filed 2017-03-27 | $2.63M derived: sum of 3 quarters · filed 2017-03-27 | |
| 2014-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $2.63M derived: sum of 2 quarters · filed 2017-03-27 | $2.63M 10-K · filed 2017-03-27 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-19 | |||
| 2013-12-31 | -$1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $910.00K derived: sum of 2 quarters · filed 2016-03-30 | $1.30M 10-K · filed 2016-03-30 | |
| 2013-09-30 | $2.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $3.11M 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | $388.00K 10-Q · filed 2014-08-15 | |||
| 2012-12-31 | $9.22M 10-K · filed 2015-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |